These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8490166)

  • 1. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
    Dale DC; Bonilla MA; Davis MW; Nakanishi AM; Hammond WP; Kurtzberg J; Wang W; Jakubowski A; Winton E; Lalezari P
    Blood; 1993 May; 81(10):2496-502. PubMed ID: 8490166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.
    Bonilla MA; Gillio AP; Ruggeiro M; Kernan NA; Brochstein JA; Abboud M; Fumagalli L; Vincent M; Gabrilove JL; Welte K; Souza LM; O'Reilly RJ
    N Engl J Med; 1989 Jun; 320(24):1574-80. PubMed ID: 2471075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
    J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
    Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of chronic severe neutropenia with weekly recombinant granulocyte-colony stimulating factor.
    Fine KD; Byrd TD; Stone MJ
    Br J Haematol; 1997 Apr; 97(1):175-8. PubMed ID: 9136962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
    Maher DW; Lieschke GJ; Green M; Bishop J; Stuart-Harris R; Wolf M; Sheridan WP; Kefford RF; Cebon J; Olver I; McKendrick J; Toner G; Bradstock K; Lieschke M; Cruickshank S; Tomita DK; Hoffman EW; Fox RM; Morstyn G
    Ann Intern Med; 1994 Oct; 121(7):492-501. PubMed ID: 7520676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
    Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
    Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group.
    Kuritzkes DR; Parenti D; Ward DJ; Rachlis A; Wong RJ; Mallon KP; Rich WJ; Jacobson MA
    AIDS; 1998 Jan; 12(1):65-74. PubMed ID: 9456256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer.
    Sagara Y; Sato K; Fukuma E; Higaki K; Mizutani M; Osaki A; Takano T; Tokuda Y; Ohno S; Masuda N; Suzuki M; Saeki T
    Jpn J Clin Oncol; 2013 Sep; 43(9):865-73. PubMed ID: 23858037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor.
    Hammond WP; Price TH; Souza LM; Dale DC
    N Engl J Med; 1989 May; 320(20):1306-11. PubMed ID: 2469956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.
    Rackoff WR; Orazi A; Robinson CA; Cooper RJ; Alter BP; Freedman MH; Harris RE; Williams DA
    Blood; 1996 Sep; 88(5):1588-93. PubMed ID: 8781414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J
    N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias.
    Bonilla MA; Dale D; Zeidler C; Last L; Reiter A; Ruggeiro M; Davis M; Koci B; Hammond W; Gillio A; Welte K
    Br J Haematol; 1994 Dec; 88(4):723-30. PubMed ID: 7529539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.
    Ganser A; Ottmann OG; Erdmann H; Schulz G; Hoelzer D
    Ann Intern Med; 1989 Dec; 111(11):887-92. PubMed ID: 2683920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
    Cottle TE; Fier CJ; Donadieu J; Kinsey SE
    Semin Hematol; 2002 Apr; 39(2):134-40. PubMed ID: 11957197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.